Close Menu

NEW YORK (GenomeWeb) — German molecular diagnostics firm Epigenomics reported on Wednesday that its third quarter revenues rose 57 percent, thanks largely to increased product sales and licensing revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.